The VISCACHA survey -- VII. Assembly history of the Magellanic Bridge and SMC Wing from star clusters

The formation scenario of the Magellanic Bridge during an encounter between the Large and Small Magellanic Clouds $\sim200\,$Myr ago, as proposed by $N$-body models, would be imprinted in the chemical enrichment and kinematics of its stars, and sites of ongoing star formation along its extension. We present an analysis of 33 Bridge star clusters using photometry obtained with the SOAR 4-m telescope equipped with adaptive optics for the VISCACHA survey. We performed a membership selection and derived self-consistent ages, metallicities, distances and reddening values via statistical isochrone fitting, as well as tidal radii and integrated masses from structure analysis. Two groups are clearly detected: 13 well-studied clusters older than the Bridge, with $0.5-6.8\,$Gyr and $\rm{[Fe/H]}<-0.6\,$dex; and 15 clusters with $-0.5\,$dex, probably formed in-situ. The old clusters follow the overall age and metallicity gradients of the SMC, whereas the younger ones are uniformly distributed along the Bridge. The main results are as follows: $(i)$ we derive ages and metallicities for the first time for 9 and 18 clusters, respectively; $(ii)$ we detect two metallicity dips in the age-metallicity relation of the Bridge at $\sim 200\,$Myr and $1.5\,$Gyr ago for the first time, possibly chemical signatures of the formation of the Bridge and Magellanic Stream; $(iii)$ we estimate a minimum stellar mass for the Bridge of $3-5 \times 10^5\,M_\odot$; $(iv)$ we confirm that all the young Bridge clusters at $\rm{RA} < 3^h$ are metal-rich $\rm{[Fe/H]} \sim -0.4\,$dex.Comment: 15 pages, 13 figures + appendix. Accepted for publication in MNRA

Terpenoid biotransformations by Mucor species

Terpenoids are natural products of great interest due to their widespread use in agrochemicals, drugs, fragrances, flavouring and pigments. Biocatalysts are increasingly being used in the search for new derivatives with improved properties especially to obtain structurally novel leads for new drugs which are difficult to obtain using conventional organic chemical methods. This review, covering up to the end of 2012, reports on the application of Mucor species as catalysts in terpenoid biotransformation to obtain new drug targets, enhance pharmacological activity or decrease the unwanted effects of starting material

Human IgG1 Responses to Surface Localised Schistosoma mansoni Ly6 Family Members Drop following Praziquantel Treatment

The heptalaminate-covered, syncytial tegument is an important anatomical adaptation that enables schistosome parasites to maintain long-term, intravascular residence in definitive hosts. Investigation of the proteins present in this surface layer and the immune responses elicited by them during infection is crucial to our understanding of host/parasite interactions. Recent studies have revealed a number of novel tegumental surface proteins including three (SmCD59a, SmCD59b and Sm29) containing uPAR/Ly6 domains (renamed SmLy6A SmLy6B and SmLy6D in this study). While vaccination with SmLy6A (SmCD59a) and SmLy6D (Sm29) induces protective immunity in experimental models, human immunoglobulin responses to representative SmLy6 family members have yet to be thoroughly explored.Using a PSI-BLAST-based search, we present a comprehensive reanalysis of the Schistosoma mansoni Ly6 family (SmLy6A-K). Our examination extends the number of members to eleven (including three novel proteins) and provides strong evidence that the previously identified vaccine candidate Sm29 (renamed SmLy6D) is a unique double uPAR/Ly6 domain-containing representative. Presence of canonical cysteine residues, signal peptides and GPI-anchor sites strongly suggest that all SmLy6 proteins are cell surface-bound. To provide evidence that SmLy6 members are immunogenic in human populations, we report IgG1 (as well as IgG4 and IgE) responses against two surface-bound representatives (SmLy6A and SmLy6B) within a cohort of S. mansoni-infected Ugandan males before and after praziquantel treatment. While pre-treatment IgG1 prevalence for SmLy6A and SmLy6B differs amongst the studied population (7.4% and 25.3% of the cohort, respectively), these values are both higher than IgG1 prevalence (2.7%) for a sub-surface tegumental antigen, SmTAL1. Further, post-treatment IgG1 levels against surface-associated SmLy6A and SmLy6B significantly drop (p = 0.020 and p < 0.001, respectively) when compared to rising IgG1 levels against sub-surface SmTAL1.Collectively, these results expand the number of SmLy6 proteins found within S. mansoni and specifically demonstrate that surface-associated SmLy6A and SmLy6B elicit immunological responses during infection in endemic communities

Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteria

Even in the setting of optimal resuscitation in high-income countries severe sepsis and septic shock have a mortality of 20–40%, with antibiotic resistance dramatically increasing this mortality risk. To develop a reference dataset enabling the identification of common bacterial targets for therapeutic intervention, we applied a standardized genomic, transcriptomic, proteomic and metabolomic technological framework to multiple clinical isolates of four sepsis-causing pathogens: Escherichia coli, Klebsiella pneumoniae species complex, Staphylococcus aureus and Streptococcus pyogenes. Exposure to human serum generated a sepsis molecular signature containing global increases in fatty acid and lipid biosynthesis and metabolism, consistent with cell envelope remodelling and nutrient adaptation for osmoprotection. In addition, acquisition of cholesterol was identified across the bacterial species. This detailed reference dataset has been established as an open resource to support discovery and translational research